Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Epigenomics AG, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
Epigenomics AG, Medical Equipment Deals By Type, 2011 to YTD 2017 7
Epigenomics AG, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
Epigenomics AG, Medical Equipment, Deals By Market, 2011 to YTD 2017 9
Epigenomics AG, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
Epigenomics AG, Medical Equipment, Deal Details 11
Partnerships 11
Biochain Institute Enters into Licensing Agreement with Epigenomics 11
Epigenomics And BioChain Expand Licensing Agreement For Septin9 12
Biochain Institute Enters Into Licensing Agreement With Epigenomics For Septin9 13
Epigenomics Enters Into Licensing Agreement With Companion Dx Reference Lab For Septin9 Biomaker 14
Epigenomics Announces Option Licensing Agreement With QIAGEN 15
Epigenomics Enters Into Research Licensing Agreement With QIAGEN 16
Epigenomics Enters Into Commercialization Agreement With Polymedco For Epi proColon 17
Epigenomics And Wuhan Kindstar Enter Into Licensing Agreement For Epi Prolung 18
Equity Offering 19
Epigenomics Raises USD6.5 Million in Private Placement of Shares 19
Epigenomics Files Draft Registration Statement for US Public Offering of Shares 20
Epigenomics Raises USD5.6 Million in Rights Offering of Shares 21
Epigenomics Raises USD5.3 Million in Private Placement of Shares 22
Epigenomics Completes Private Placement Of Shares For US$4.5 Million 24
Epigenomics Announces Private Placement Of Shares For US$1.3 Million 25
Epigenomics Completes Rights Issue Of Common Stock For US$6 Million 26
Epigenomics Completes Private Placement Of Shares For US$0.7 Million 27
Debt Offering 28
Epigenomics Raises USD8.5 Million in Private Placement of Bonds 28
Epigenomics Announces Private Placement Of Bonds For US$6.7 Million 29
Acquisition 30
Cathay Fortune International to Acquire Epigenomics 30
Epigenomics AG – Key Competitors 32
Epigenomics AG – Key Employees 33
Epigenomics AG – Locations And Subsidiaries 34
Head Office 34
Other Locations & Subsidiaries 34
Recent Developments 35
Financial Announcements 35
Jul 06, 2017: Epigenomics issues change in guidance for financial year 2017 35
May 10, 2017: Epigenomics announces 2017 First Quarter Financial Results 36
Apr 26, 2017: Epigenomics Reports Results for Financial Year 2016 37
Nov 09, 2016: Epigenomics Announces 2016 Third Quarter and Nine Months Financial Results and Reports on Operational Highlights 38
Aug 10, 2016: Epigenomics Announces 2016 Second Quarter and Six Months Financial Results and Reports on Operational Highlights 40
May 23, 2016: Epigenomics Announces 2016 First Quarter Financial Results and Reports on Operational Highlights 41
Mar 18, 2016: Epigenomics Reports Results for the Financial Year Ended December 31, 2015 and Provides Outlook for 2016 42
Corporate Communications 44
Nov 05, 2017: Supervisory Board of Epigenomics Appoints Dr. Jorge Garces as President and Chief Scientific Officer 44
Jun 30, 2016: Supervisory Board of Epigenomics appoints Gregory Hamilton as Chief Executive Officer (CEO) 45
Product News 46
Apr 18, 2016: Epigenomics to present data on novel blood-based test for the detection of lung cancer at AACR Annual Meeting 2016 46
Appendix 47
Methodology 47
About GlobalData 47
Contact Us 47
Disclaimer 47
Epigenomics AG, Medical Equipment, Key Facts, 2016 2
Epigenomics AG, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Epigenomics AG, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
Epigenomics AG, Medical Equipment Deals By Type, 2011 to YTD 2017 7
Epigenomics AG, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
Epigenomics AG, Deals By Market, 2011 to YTD 2017 9
Epigenomics AG, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
Biochain Institute Enters into Licensing Agreement with Epigenomics 11
Epigenomics And BioChain Expand Licensing Agreement For Septin9 12
Biochain Institute Enters Into Licensing Agreement With Epigenomics For Septin9 13
Epigenomics Enters Into Licensing Agreement With Companion Dx Reference Lab For Septin9 Biomaker 14
Epigenomics Announces Option Licensing Agreement With QIAGEN 15
Epigenomics Enters Into Research Licensing Agreement With QIAGEN 16
Epigenomics Enters Into Commercialization Agreement With Polymedco For Epi proColon 17
Epigenomics And Wuhan Kindstar Enter Into Licensing Agreement For Epi Prolung 18
Epigenomics Raises USD6.5 Million in Private Placement of Shares 19
Epigenomics Files Draft Registration Statement for US Public Offering of Shares 20
Epigenomics Raises USD5.6 Million in Rights Offering of Shares 21
Epigenomics Raises USD5.3 Million in Private Placement of Shares 22
Epigenomics Completes Private Placement Of Shares For US$4.5 Million 24
Epigenomics Announces Private Placement Of Shares For US$1.3 Million 25
Epigenomics Completes Rights Issue Of Common Stock For US$6 Million 26
Epigenomics Completes Private Placement Of Shares For US$0.7 Million 27
Epigenomics Raises USD8.5 Million in Private Placement of Bonds 28
Epigenomics Announces Private Placement Of Bonds For US$6.7 Million 29
Cathay Fortune International to Acquire Epigenomics 30
Epigenomics AG, Key Competitors 32
Epigenomics AG, Key Employees 33
Epigenomics AG, Subsidiaries 34